arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

OSR Health, Inc.

OSRH

$0.14 0.00 (0.00%) at close

20 Visible periods

28 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, OSR Health, Inc. shows weak fundamentals, weighed down by FCF Margin (%) and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth -72.2% ↘

Op. Margin None

ROIC -777.4% ↗

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 25, 2026.

20-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$315.67K

↓ -72.2% —

Net Income Profit after all expenses

$-3.47M

↑ +69.6% —

Operating Margin Operating profit as % of sales

-460.5%

↓ -20.1% —

FCF / Share Free cash flow per share

$-0.03

↓ -446.4% —

Long-Term Debt Long-term obligations

$271.35K

↓ -0.6% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF Margin (%)FCF Margin (%) of -148.9% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -36.18x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.16x is weak on an absolute basis (target > 1x)

Health Breakdown

Profitability ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-72.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1003%)	-36.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-555%)	-58.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-829%)	-23.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-397%)	28.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+260%)	-16.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-305%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	91.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	74.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-73.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-6100.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	N/M	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	69.6% Excellent ↑ Excellent Improving Year-over-year change in net income	69.6% Excellent ↑ Excellent Improving Year-over-year change in net income	—	4.8% Caution ↑ Caution Improving Year-over-year change in net income	-239.5% Weak Weak Year-over-year change in net income	-239.5% Weak Weak Year-over-year change in net income	—	N/M	N/M	N/M	-504.6% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	—	—	—	—	—	—
FCF Growth YoY (%)	—	-446.4% Weak Weak Year-over-year change in free cash flow	—	—	—	93.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	—	—	—	-460.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3170%)	-383.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2655%)	-176.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1275%)	-433.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2989%)	-364.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2527%)	-362.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2519%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	30.4% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	11.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	28.8% Caution Caution Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	25.2% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	29.9% Caution Caution Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	-407.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3499%)	-380.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3271%)	-368.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3172%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-207.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-280.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-431.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-8.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-19.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-83.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-54.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-54.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.70x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	3.24x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-30.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	55.13x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-777.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-1188.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-910.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-242.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-1.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	—	—	—	—	—	—	—	—	—	—	2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-6.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	38.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+153%)	0.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-96%)	3.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	5.6% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-243.81x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-115.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-86.69x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-171.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-96.69x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-331.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-245.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	-51602.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$871.34K	$930.35K	$623.20K	$-317.41K	$185.96K	$306.52K	$1.96M	—	—	—	$-15.42K	$-57.95K	$-1.18K	$-348.80K	$-124.50K	—	—	—	$-4.76K	—
Debt / EBITDA (x)	-0.78x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.68x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.36x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.49x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.34x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.65x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.39x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	—	$0.02	—	—	—	$0.07	—	—	—	$0.16	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.02	$-0.09	$-0.16	$-0.10	$0.02	$-1.04	$-0.62	$-1.56	$-0.41	$-0.60	$-0.01	$0.01	$0.03	—	$0.00	$-0.01	$0.00	—	—	—
Free Cash Flow per Share (USD)	—	$-0.03	—	—	—	$-0.01	—	—	—	$-0.09	—	—	—	—	—	$0.00	$-0.00	—	—	—
Book Value per Share (USD)	—	—	—	—	—	—	—	—	—	—	$-1.81	$-1.14	$-0.97	$-0.85	$-0.02	$-0.02	$-0.00	$-0.00	$-0.00	—
Tangible Book Value per Share (USD)	—	—	—	—	—	—	—	—	—	—	$-1.81	$-1.14	$-0.97	$-0.85	$-0.02	$-0.02	$-0.00	$-0.00	$-0.00	—
Basic Weighted Avg Shares (shares)	—	31.21M	—	—	—	10.91M	—	—	—	5.62M	—	9.05M	9.05M	—	—	1.50M	1.50M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-12.87M	$-14.97M	$-14.35M	$-11.83M	$-12.98M	$-10.42M	$-1.14M	—	—	—	$-2.02M	$-1.02M	$-482.39K	$26.44K	$-1.14M	—	—	—	$-702.45K	—
LT Debt (USD)	$271.35K	$272.91K	—	$0.00	—	$253.04K	$497.62K	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	—	—	—	—	—	—	—	—	—	—	$-3.91M	$-2.45M	$-2.09M	$-1.83M	$-37.51K	$-23.26K	$-3.23K	$-2.25K	$-2.12K	$1.19K

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$315.67K	$484.06K	$381.27K	$627.75K	$1.14M	$761.27K	$915.25K	$823.00K	$881.83K	$910.23K	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$9.61K	$7.90K	$6.38K	$313.00	—	$378.00	$-41.95K	$43.91K	$-13.00K	$16.94K	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.47M	$-3.47M	—	$-3.19M	$-11.39M	$-11.39M	—	$-3.36M	$-3.36M	$-3.36M	$-86.17K	$110.31K	$110.31K	$110.31K	$-14.25K	$-126.00	$-126.00	$-126.00	—	—
Operating Cash Flow (USD)	$-2.42M	$-1.00M	$-1.07M	$-2.71M	—	$-64.07K	$-181.03K	$-686.45K	$-483.21K	$-498.78K	$-279.49K	—	—	$-48.43K	$-952.00	$3.79K	$-6.95K	$-126.00	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 20 quarters

OSR Health, Inc.

Analytical Summary

20-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare OSRH with peers